'84 Law Angers Defense Contractors

WASHINGTON—A 1984 law to encourage competition among defense contractors has forced federal agencies to become aware of the importance of evaluating all possible bidders for contracts, but also has slowed the procurement process and angered many industry officials. The Competition in Contracting Act was an attempt by Congress to end "sweetheart" deals between the Pentagon and individual defense contractors. Its requirement that agencies seek bids from a range of contractors has led some ag

Written byDaniel Charles
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The Competition in Contracting Act was an attempt by Congress to end "sweetheart" deals between the Pentagon and individual defense contractors. Its requirement that agencies seek bids from a range of contractors has led some agencies to give out fewer, but larger, awards. Although research, including money to university-based contractors, forms only, a small portion of the Defense Department's $300 billion annual budget, it is expected to amount to $10 billion in the coming fiscal year—$3 billion for basic technology and $7 billion for advanced technology and development.

Some industry officials believe the cure has been worse than the disease. Two federal agencies, in fact, are experimenting with procedures to streamline a process that now takes almost twice as long as it did before the law was passed.

Earle Williams, president of BDM International Inc., a leading high-technology research firm, has become the R&D industry's most prominent critic of the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery